LEP and non-small cell lung carcinoma: Among them, some studies have found that elevated serum leptin levels represent an independent risk factor for non-small-cell lung cancer (NSCLC) [13–15], whereas other studies have reported significant correlation between decreased serum leptin levels and prognosis in lung cancer [16, 17].